From: Cancer Trajectories at the End of Life: is there an effect of age and gender?
Probability to be free from functional disability (weeks before death) | ||||||||
---|---|---|---|---|---|---|---|---|
N. | 52 weeks % (95% CI) | 24 weeks % (95% CI) | 18 weeks % (95% CI) | 12 weeks % (95% CI) | 6 weeks % (95% CI) | 4 weeks % (95% CI) | 2 weeks % (95% CI) | |
Gender | ||||||||
Men | 700 | 95 (93–97) | 92 (89–94) | 91 (88–93) | 68 (63–73) | 53 (49–58) | 39 (35–44) | 27 (23–31) |
Women | 549 | 92 (89–94) | 88 (84–91) | 86 (82–89) | 56 (51–62) | 43 (37–48) | 26 (21–31) | 18 (15–22) |
Age at death | ||||||||
18–64 | 242 | 99 (96–99) | 95 (91–97) | 93 (89–96) | 74 (68–80) | 62 (55–68) | 43 (36–50) | 30 (25–36) |
65–84 | 785 | 94 (92–96) | 92 (89–94) | 90 (86–92) | 63 (58–68) | 47 (43–51) | 32 (28–36) | 22 (19–25) |
85 + | 222 | 85 (79–90) | 80 (74–85) | 79 (73–84) | 50 (42–58) | 41 (34–47) | 28 (23–33) | 19 (14–24) |
Primary Tumour | ||||||||
Digestive | 453 | 94 (92–96) | 91 (88–94) | 90 (87–92) | 65 (60–70) | 53 (48–58) | 35 (30–40) | 23 (19–27) |
Respiratory | 262 | 97 (93–99) | 94 (90–96) | 91 (85–95) | 69 (61–76) | 52 (45–59) | 39 (32–46) | 28 (23–34) |
Breast | 124 | 91 (83–95) | 88 (80–93) | 87 (80–91) | 58 (49–67) | 45 (35–55) | 24 (15–37) | 19 (12–29) |
Genitourinary | 184 | 93 (87–97) | 87 (80–92) | 85 (80–90) | 59 (49–68) | 41 (33–49) | 28 (21–36) | 15 (11–23) |
Hematological | 91 | 91 (83–95) | 90 (82–94) | 88 (80–93) | 62 (52–72) | 52 (42–62) | 40 (32–49) | 30 (22–40) |
Nervous Central System | 32 | 87 (67–96) | 76 (59–87) | 72 (56–84) | 46 (26–68) | 35 (19–55) | 14 (5–31) | 6 (2–19) |
Others | 103 | 92 (84–96) | 90 (82–95) | 90 (81–95) | 60 (44–74) | 42 (31–55) | 37 (27–49) | 28 (18–40) |
All patients | 1,249 | 94 (92–95) | 90 (88–93) | 88 (86–91) | 63 (58–68) | 49 (45–53) | 33 (30–37) | 23 (20–26) |